Literature DB >> 17237124

Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region.

Anne Ronan, Kerry Fagan, Louise Christie, Jeffrey Conroy, Norma J Nowak, Gillian Turner.   

Abstract

A 4.3 Mb duplication of chromosome 21 bands q22.13-q22.2 was diagnosed by interphase fluorescent in-situ hybridisation (FISH) in a 31-week gestational age baby with cystic hygroma and hydrops; the duplication was later found in the mother and in her 8-year-old daughter by the same method and confirmed by array comparative genomic hybridisation (aCGH). All had the facial gestalt of Down syndrome (DS). This is the smallest accurately defined duplication of chromosome 21 reported with a DS phenotype. The duplication encompasses the gene DYRK1 but not DSCR1 or DSCAM, all of which have previously been implicated in the causation of DS. Previous karyotype analysis and telomere screening of the mother, and karyotype analysis and metaphase FISH of a chorionic villus sample, had all failed to reveal the duplication. The findings in this family add to the identification and delineation of a "critical region" for the DS phenotype on chromosome 21. Cryptic chromosomal abnormalities can be missed on a routine karyotype for investigation of abnormal prenatal ultrasound findings, lending support to the use of aCGH analysis in this setting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237124      PMCID: PMC2598003          DOI: 10.1136/jmg.2006.047373

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype.

Authors:  M V Senat; B De Keersmaecker; F Audibert; G Montcharmont; R Frydman; Y Ville
Journal:  Prenat Diagn       Date:  2002-05       Impact factor: 3.050

Review 2.  Increased nuchal translucency in fetuses with a normal karyotype.

Authors:  Jon A Hyett
Journal:  Prenat Diagn       Date:  2002-10       Impact factor: 3.050

3.  Detection of large-scale variation in the human genome.

Authors:  A John Iafrate; Lars Feuk; Miguel N Rivera; Marc L Listewnik; Patricia K Donahoe; Ying Qi; Stephen W Scherer; Charles Lee
Journal:  Nat Genet       Date:  2004-08-01       Impact factor: 38.330

4.  Fine-scale structural variation of the human genome.

Authors:  Eray Tuzun; Andrew J Sharp; Jeffrey A Bailey; Rajinder Kaul; V Anne Morrison; Lisa M Pertz; Eric Haugen; Hillary Hayden; Donna Albertson; Daniel Pinkel; Maynard V Olson; Evan E Eichler
Journal:  Nat Genet       Date:  2005-05-15       Impact factor: 38.330

5.  Down syndrome with partial duplication and del (21) syndrome: study protocol and call for collaboration. Study I: Clinical assessment.

Authors:  A J Barnicoat; J L Bonneau; E Boyd; Z Docherty; S J Fennell; J L Huret; M King; E L Maltby; S McManus; D T Pilz; E Shafei-Benaissa; M Super; J Tolmie
Journal:  Clin Genet       Date:  1996-01       Impact factor: 4.438

6.  Confirmation of Down syndrome critical region by FISH analysis in a patient with add(21) (p11)

Authors:  N Matsumoto; N Niikawa; M Mikawa
Journal:  Am J Med Genet       Date:  1995-12-04

7.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.

Authors:  J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

8.  Large-scale copy number polymorphism in the human genome.

Authors:  Jonathan Sebat; B Lakshmi; Jennifer Troge; Joan Alexander; Janet Young; Pär Lundin; Susanne Månér; Hillary Massa; Megan Walker; Maoyen Chi; Nicholas Navin; Robert Lucito; John Healy; James Hicks; Kenny Ye; Andrew Reiner; T Conrad Gilliam; Barbara Trask; Nick Patterson; Anders Zetterberg; Michael Wigler
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

9.  Pregnancy outcome of 30 fetuses with cystic hygroma diagnosed during the first 15 weeks of gestation.

Authors:  A Paoloni-Giacobino; D Extermann; Ph Extermann; S Y Dahoun
Journal:  Genet Couns       Date:  2003

10.  NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

Authors:  Joseph R Arron; Monte M Winslow; Alberto Polleri; Ching-Pin Chang; Hai Wu; Xin Gao; Joel R Neilson; Lei Chen; Jeremy J Heit; Seung K Kim; Nobuyuki Yamasaki; Tsuyoshi Miyakawa; Uta Francke; Isabella A Graef; Gerald R Crabtree
Journal:  Nature       Date:  2006-03-22       Impact factor: 49.962

View more
  18 in total

1.  Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes.

Authors:  Mireia Vilardell; Axel Rasche; Anja Thormann; Elisabeth Maschke-Dutz; Luis A Pérez-Jurado; Hans Lehrach; Ralf Herwig
Journal:  BMC Genomics       Date:  2011-05-11       Impact factor: 3.969

2.  Mice deficient in cystathionine beta synthase display increased Dyrk1A and SAHH activities in brain.

Authors:  Chris Planque; Julien Dairou; Christophe Noll; Linh-Chi Bui; Clémentine Ripoll; Fayçal Guedj; Jean-Maurice Delabar; Nathalie Janel
Journal:  J Mol Neurosci       Date:  2012-06-15       Impact factor: 3.444

3.  The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies.

Authors:  Jan O Korbel; Tal Tirosh-Wagner; Alexander Eckehart Urban; Xiao-Ning Chen; Maya Kasowski; Li Dai; Fabian Grubert; Chandra Erdman; Michael C Gao; Ken Lange; Eric M Sobel; Gillian M Barlow; Arthur S Aylsworth; Nancy J Carpenter; Robin Dawn Clark; Monika Y Cohen; Eric Doran; Tzipora Falik-Zaccai; Susan O Lewin; Ira T Lott; Barbara C McGillivray; John B Moeschler; Mark J Pettenati; Siegfried M Pueschel; Kathleen W Rao; Lisa G Shaffer; Mordechai Shohat; Alexander J Van Riper; Dorothy Warburton; Sherman Weissman; Mark B Gerstein; Michael Snyder; Julie R Korenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-13       Impact factor: 11.205

4.  Molecular rescue of DYRK1A overexpression in cystathionine beta synthase-deficient mouse brain by enriched environment combined with voluntary exercise.

Authors:  Benoit Souchet; Alizée Latour; Yuchen Gu; Fabrice Daubigney; Jean-Louis Paul; Jean-Maurice Delabar; Nathalie Janel
Journal:  J Mol Neurosci       Date:  2014-05-13       Impact factor: 3.444

5.  Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.

Authors:  Rikke S Møller; Sabine Kübart; Maria Hoeltzenbein; Babett Heye; Ida Vogel; Christian P Hansen; Corinna Menzel; Reinhard Ullmann; Niels Tommerup; Hans-Hilger Ropers; Zeynep Tümer; Vera M Kalscheuer
Journal:  Am J Hum Genet       Date:  2008-04-10       Impact factor: 11.025

6.  Implications of copy number variation in people with chromosomal abnormalities: potential for greater variation in copy number state may contribute to variability of phenotype.

Authors:  Adam J de Smith; Anne L Trewick; Alexandra I F Blakemore
Journal:  Hugo J       Date:  2010-08-10

Review 7.  TTC3-Mediated Protein Quality Control, A Potential Mechanism for Cognitive Impairment.

Authors:  Xu Zhou; Xiongjin Chen; Tingting Hong; Miaoping Zhang; Yujie Cai; Lili Cui
Journal:  Cell Mol Neurobiol       Date:  2021-02-27       Impact factor: 4.231

8.  Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1.

Authors:  Barbara Maenz; Paul Hekerman; Eva M Vela; Juan Galceran; Walter Becker
Journal:  BMC Mol Biol       Date:  2008-03-26       Impact factor: 2.946

9.  Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A.

Authors:  Fayçal Guedj; Catherine Sébrié; Isabelle Rivals; Aurelie Ledru; Evelyne Paly; Jean C Bizot; Desmond Smith; Edward Rubin; Brigitte Gillet; Mariona Arbones; Jean M Delabar
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

10.  An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model.

Authors:  Afua Mensah; Claire Mulligan; Jackie Linehan; Sandra Ruf; Aideen O'Doherty; Beata Grygalewicz; Janet Shipley; Juergen Groet; Victor Tybulewicz; Elizabeth Fisher; Sebastian Brandner; Dean Nizetic
Journal:  BMC Dev Biol       Date:  2007-11-29       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.